{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:35:05Z","timestamp":1767144905608,"version":"build-2238731810"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.cyto.2010.12.004","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T04:15:59Z","timestamp":1294287359000},"page":"384-389","source":"Crossref","is-referenced-by-count":18,"title":["Chemokine\/cytokine profiling after rituximab: Reciprocal expression of BCA-1\/CXCL13 and BAFF in childhood OMS"],"prefix":"10.1016","volume":"53","author":[{"given":"Michael R.","family":"Pranzatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna L.","family":"Travelstead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2010.12.004_b0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.coi.2007.04.008","article-title":"B cells and the BAFF\/APRIL axis: fast-forward on autoimmunity and signaling","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cyto.2010.12.004_b0015","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/bi048227k","article-title":"Selectivity of BAFF\/BLyS and APRIL for binding to the TNF family receptors BAFFR\/BR3 and BCMA","volume":"44","author":"Day","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cyto.2010.12.004_b0020","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus\u2013myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.cyto.2010.12.004_b0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2008.01.007","article-title":"B and T cell imbalances in CSF of patients with Hu-antibody associated PNS","volume":"195","author":"de Graaf","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.mph.0000212991.64435.f0","article-title":"Rituximab (anti-CD20) adjunctive therapy for opsoclonus\u2013myoclonus syndrome","volume":"28","author":"Pranzatelli","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cyto.2010.12.004_b0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10875-009-9335-3","article-title":"Long-term cerebrospinal fluid and blood lymphocyte dynamics after rituximab for pediatric opsoclonus\u2013myoclonus","volume":"30","author":"Pranzatelli","year":"2010","journal-title":"J Clin Immunol"},{"issue":"5","key":"10.1016\/j.cyto.2010.12.004_b0040","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MPH.0b013e3181cf0726","article-title":"Pediatric dosing of rituximab revisited: serum concentrations in opsoclonus\u2013myoclonus syndrome","volume":"32","author":"Pranzatelli","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cyto.2010.12.004_b0045","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-3083.2005.01688.x","article-title":"The BAFF\/APRIL system in systemic autoimmune diseases with a special emphasis on Sj\u0151gren\u2019s syndrome","volume":"62","author":"Szodoray","year":"2005","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0050","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sj\u0151gren\u2019s syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2010.12.004_b0055","doi-asserted-by":"crossref","first-page":"R167","DOI":"10.1186\/ar2076","volume":"8","author":"Vallerskog","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cyto.2010.12.004_b0060","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/ard.2006.062505","article-title":"Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis","volume":"66","author":"Toubi","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2010.12.004_b0065","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1002\/eji.200636791","article-title":"Essential role of antigen-presenting cell-derived BAFF for antibody responses","volume":"37","author":"Bergamin","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2010.12.004_b0075","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2353\/ajpath.2008.071139","article-title":"Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta","volume":"172","author":"Langat","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cyto.2010.12.004_b0165","doi-asserted-by":"crossref","first-page":"ii25","DOI":"10.1136\/ard.62.suppl_2.ii25","article-title":"Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease","volume":"62","author":"Melchers","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cyto.2010.12.004_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1196\/annals.1313.004","article-title":"BAFF overexpression is associated with autoantibody production in autoimmune diseases","volume":"1050","author":"Pers","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.cyto.2010.12.004_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus\u2013myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2010.12.004_b0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2006.06431.x","article-title":"High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura","volume":"136","author":"Emmerich","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cyto.2010.12.004_b0100","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1080\/00365520701452225","article-title":"Elevated B cell-activating factor of the tumour necrosis factor family in celiac disease","volume":"42","author":"Fabris","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cyto.2010.12.004_b0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000094897","article-title":"B cell-activating factor is a novel diagnosis parameter for asthma","volume":"141","author":"Kang","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaut.2005.08.004","article-title":"BAFF is elevated in serum of patients with Wegener\u2019s granulomatosis","volume":"25","author":"Krumbholz","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.cyto.2010.12.004_b0115","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2010.12.004_b0120","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.175.5.2814","article-title":"B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells","volume":"175","author":"Yang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0125","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.4049\/jimmunol.179.9.5947","article-title":"In vitro and in vivo activation induces BAFF and APRIL expression in B cells","volume":"179","author":"Chu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2010.12.004_b0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.192.1.129","article-title":"BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population","volume":"192","author":"Thompson","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2010.12.004_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3899\/jrheum.090450","article-title":"Serum BCL\/CXCL13 concentrations and renal expression of CXCL13\/CXCL15 in patients with systemic lupus erythematosus and lupus nephritis","volume":"37","author":"Lee","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cyto.2010.12.004_b0145","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/art.22603","article-title":"BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sj\u0151gren\u2019s syndrome","volume":"56","author":"Pers","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cyto.2010.12.004_b0150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood-2005-06-2383","article-title":"The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis","volume":"108","author":"Meraouna","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2010.12.004_b0155","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2004-02-0701","article-title":"Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis","volume":"104","author":"Carlsen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2010.12.004_b0160","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.182.3.1541","article-title":"Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses","volume":"182","author":"Maier","year":"2009","journal-title":"J Immunol"}],"updated-by":[{"DOI":"10.1016\/j.cyto.2016.07.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000}}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466610007751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466610007751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T13:54:20Z","timestamp":1544018060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466610007751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1043466610007751"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2010.12.004","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}